Our pharma partners in the Milner Therapeutics Consortium work together with academics at the University, Babraham and Wellcome Sanger Institutes to better understand disease mechanisms and to discover and validate new therapeutic targets. These pre-clinical projects range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations and are expected to lead to joint publications with the company partners.

Do you have an idea for a potential pre-clinical collaborative project that would benefit from industry expertise and know-how?

We are looking for project proposals that could provide solutions to current challenges in:

Neuroscience
Oncology
Immunology & Inflammation
Infectious Disease
Reproductive Medicine
Metabolic & Cardiovascular disease
New technologies that will aid therapeutic discovery

What we can provide:
Support for pilot (6 months) or longer-term projects (1-2 years)
Funding e.g. for a research associate and consumables
Access to company reagents where appropriate e.g. tool compounds, compound libraries
Expertise e.g. in particular techniques, disease areas, target selection and validation

Important Dates:
16th January 2023 – Call opens for applications
24th March 2023 – Closing date for applications

Visit: https://www.milner.cam.ac.uk/consorti...